Age Related Multiple Sclerosis Severity Score: Disability ranked by age

Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences

(2015) Petter Brodin et al.   CELL

Long-term influence of combined oral contraceptive use on the clinical course of relapsing–remitting multiple sclerosis

(2014) Giulia Gava et al.   FERTILITY AND STERILITY

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study

(2013) Ali Manouchehrinia et al.   BRAIN

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

(2013) Ashley H Beecham et al.   NATURE GENETICS

From the Gothenburg cohort to the Swedish multiple sclerosis registry

(2012) O. Andersen   ACTA NEUROLOGICA SCANDINAVICA

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

(2012) Afsaneh Shirani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genome-wide association study of severity in multiple sclerosis

(2011)   GENES AND IMMUNITY

Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium

(2011) Ilya Kister et al.   Multiple Sclerosis Journal

Vitamin D in African Americans with multiple sclerosis

(2011) J. M. Gelfand et al.   NEUROLOGY

Age and disability accumulation in multiple sclerosis

(2011) A. Scalfari et al.   NEUROLOGY

Emerging effects of comorbidities on multiple sclerosis

(2010) Ruth Ann Marrie et al.   LANCET NEUROLOGY

The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation

(2010) Richard C Strange et al.   Multiple Sclerosis Journal

Rapid disease course in African Americans with multiple sclerosis

(2010) I. Kister et al.   NEUROLOGY

New perspectives in the natural history of multiple sclerosis

(2010) H. Tremlett et al.   NEUROLOGY

The multiple sclerosis severity score (MSSS) predicts disease severity over time

(2009) Andrew R. Pachner et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid

(2009) J. Mellergård et al.   Multiple Sclerosis Journal

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

(2008) Sergio E. Baranzini et al.   HUMAN MOLECULAR GENETICS

Relapses in multiple sclerosis are age- and time-dependent

(2008) H Tremlett et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY